These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24938355

  • 1. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.
    Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, Hirota S, Haga H, Katsuyama E.
    World J Surg Oncol; 2014 Jun 18; 12():186. PubMed ID: 24938355
    [Abstract] [Full Text] [Related]

  • 2. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.
    Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP.
    Mod Pathol; 2007 May 18; 20(5):592-603. PubMed ID: 17396140
    [Abstract] [Full Text] [Related]

  • 3. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
    Tsuzuki T, Magi-Galluzzi C, Epstein JI.
    Am J Surg Pathol; 2004 Dec 18; 28(12):1609-14. PubMed ID: 15577680
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
    Zarei S, Abdul-Karim FW, Chase DM, Astbury C, Policarpio-Nicolas MLC.
    Int J Gynecol Pathol; 2020 Mar 18; 39(2):152-156. PubMed ID: 30741845
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
    Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA.
    Am J Surg Pathol; 2005 Oct 18; 29(10):1348-55. PubMed ID: 16160478
    [Abstract] [Full Text] [Related]

  • 8. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
    Inamura K, Kobayashi M, Nagano H, Sugiura Y, Ogawa M, Masuda H, Yonese J, Ishikawa Y.
    Hum Pathol; 2017 Nov 18; 69():96-100. PubMed ID: 28504207
    [Abstract] [Full Text] [Related]

  • 9. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
    Choi E, Williamson SR, Montironi R, Zhang S, Wang M, Eble JN, Grignon DJ, Lopez-Beltran A, Idrees MT, Baldridge LA, Scarpelli M, Jones CL, Wang L, MacLennan GT, Osunkoya AO, Cheng L.
    Histopathology; 2015 Jul 18; 67(1):20-38. PubMed ID: 25406945
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours.
    Yamamoto H, Nozaki Y, Kohashi K, Kinoshita I, Oda Y.
    Histopathology; 2020 Apr 18; 76(5):774-778. PubMed ID: 31578734
    [Abstract] [Full Text] [Related]

  • 11. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.
    Wada T, Tanabe S, Ishido K, Higuchi K, Sasaki T, Katada C, Azuma M, Naruke A, Kim M, Koizumi W, Mikami T.
    World J Gastroenterol; 2013 Dec 21; 19(47):9133-6. PubMed ID: 24379641
    [Abstract] [Full Text] [Related]

  • 12. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
    Zhang YH, Zhang XR, Yu J, Li HL.
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug 08; 47(8):585-590. PubMed ID: 30107662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
    Liegl B, Hornick JL, Corless CL, Fletcher CD.
    Am J Surg Pathol; 2009 Mar 08; 33(3):437-46. PubMed ID: 19011564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy.
    Antonescu CR, Romeo S, Zhang L, Nafa K, Hornick JL, Nielsen GP, Mino-Kenudson M, Huang HY, Mosquera JM, Dei Tos PA, Fletcher CD.
    Am J Surg Pathol; 2013 Mar 08; 37(3):385-92. PubMed ID: 23348204
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory myofibroblastic tumors of the urinary bladder: a systematic review.
    Teoh JY, Chan NH, Cheung HY, Hou SS, Ng CF.
    Urology; 2014 Sep 08; 84(3):503-8. PubMed ID: 25168523
    [Abstract] [Full Text] [Related]

  • 19. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks.
    Hwang DG, Qian X, Hornick JL.
    Am J Clin Pathol; 2011 Mar 08; 135(3):448-53. PubMed ID: 21350101
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.